Screener
ANI Pharmaceuticals ANIP Number of pharmaceutical manufacturing facilities
Number of pharmaceutical manufacturing facilities at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept anip:NumberOfPharmaceuticalManufacturingFacilities.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
The Company owns and operates three pharmaceutical manufacturing facilities, which include two facilities in Baudette, Minnesota and one in East Windsor, New Jersey, which collectively are capable of producing oral solid dose products, as well as semi-solids, liquids and topicals, controlled substances, and potent products that must be manufactured in a fully-contained environment.
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is ANI Pharmaceuticals's number of pharmaceutical manufacturing facilities?
- ANI Pharmaceuticals (ANIP) reported number of pharmaceutical manufacturing facilities of $3 in Q2 2026.
- How has ANI Pharmaceuticals's number of pharmaceutical manufacturing facilities changed year-over-year?
- ANI Pharmaceuticals's number of pharmaceutical manufacturing facilities decreased by 0.0% year-over-year, from $3 to $3.
- What does number of pharmaceutical manufacturing facilities mean?
- Number of pharmaceutical manufacturing facilities as reported by ANI Pharmaceuticals, Inc..
Ask your AI about ANI Pharmaceuticals's number of pharmaceutical manufacturing facilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude